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5th October, 2017 
 
Deputy Maureen O'Sullivan, 
 Dáil Eireann, 
 Kildare Street, 
 Dublin 2. 
 
 
PQ 41001/17 
* To ask the Minister for Health the number of persons being prescribed methadone in 2017; the 
number that have been prescribed methadone for more than ten years; and if, since the 
introduction of methadone in 1971, longitudinal research has been carried out to examine its 
effectiveness. 
 
Dear Deputy O'Sullivan, 
 
The Health Service Executive has been requested to reply directly to your above Parliamentary 
Question which you submitted to the Minister for Health for response. I have examined the matter 
and the following outlines the position: 
 
As of the end of August ’17 there were 10,161 patients receiving Methadone Treatment 
(including prisons).  
 
The most recent available data for length of time in treatment is as of 31st of December 2016. At 
this time there were 10,087 patients receiving Methadone Treatment (including prisons) of which 
3,754 (37%) of patients were in treatment for 10 years or more.  
 
Since the introduction of methadone, there has been a significant longitudinal research study, the 
ROSIE (Research Outcome Study in Ireland) study. This demonstrated clear evidence that 
Methadone treatment works. This was a National prospective longitudinal drug treatment 
outcome study and the outcomes from the ROSIE study showed both that drug treatment works 
and that investment in drug treatment pays dividends.  Significant reductions were shown in the 
key outcome areas of drug use, involvement in crime and injecting drug use.  In addition 
improvements were seen in employment and training. Thus the ROSIE results are comparable 
with the positive outcomes reported by similar studies in the US (DARP & DATOS) the UK 
(NTORS) & Australia (ATOS).  
 
There is international research evidence that increased length of time in OST is associated with 
improved treatment outcomes (including reduced use of other opioids and reduced criminal 
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activity) and short-term methadone maintenance treatment is associated with poorer outcomes 
(Ward J, Mattick RP and Hall W (1998)) 
 
Evidence strongly suggests that time limiting Opioid Substitute Treatment may have significant 
unintended consequences including increasing drug-driven crime (and national crime statistics), 
increasing heroin overdose death rates and increasing the spread of blood-borne viruses 
including hepatitis and HIV. Those implementing this approach could also face medico-legal 
challenges. 
 
I trust this information is of assistance to you but should you have any further queries please 
contact me. 
 
Yours sincerely, 
 
 
__________ 
Joseph Doyle 
National Planning Specialist 
 
 
